Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.5%
    Check dated 2025-05-08T13:50:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-05-01T06:13:01.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-24T00:14:39.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of a clinical trial for CX-2029 and the addition of a new revision number. The names of the study and the types of cancers involved remain consistent, but the detailed study information has been deleted.
    Difference
    26%
    Check dated 2025-04-16T20:26:18.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T13:31:16.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-25T15:31:09.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.